Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 11.9B | 11.9B | 12.6B | 12.7B |
Cost of revenue | 10.0B | 10.1B | 10.8B | 11.0B |
Gross profit | 1.9B | 1.8B | 1.8B | 1.7B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 264M | 255M | 224M | 222M |
Other operating expenses | 2M | 0 | 1M | 1M |
Operating income | 1.6B | 1.5B | 1.6B | 1.5B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | -2M | 4M | 11M | 14M |
Other income expense | 51M | 60M | 44M | 35M |
Pretax income | 1.7B | 1.6B | 1.6B | 1.5B |
Tax provision | 400M | 350M | 366M | 356M |
Net income | 1.3B | 1.2B | 1.2B | 1.1B |
Basic EPS | 2.5 | 2.4 | 2.3 | 2.1 |
Diluted EPS | 2.5 | 2.4 | 2.3 | 2.1 |
Basic average shares | 509M | 514.7M | 530.9M | 537.0M |
Diluted average shares | 510.2M | 516.5M | 531.9M | 537M |
EBITDA | 2.2B | 2.0B | 2.1B | 1.9B |
Net income from continuing op. | 1.3B | 1.2B | 1.2B | 1.1B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |